Global COPD Medicine Market Research Report 2023
This is drugs for COPD
According to QYResearch’s new survey, global COPD Medicine market is projected to reach US$ 42620 million in 2029, increasing from US$ 28670 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COPD Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global COPD Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global COPD Medicine market is projected to reach US$ 42620 million in 2029, increasing from US$ 28670 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COPD Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global COPD Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- GSK
- AstraZeneca
- Boehringer Ingelheim
- Vertex
- Roche
- Novartis
- Teva
- Chiesi
- Viatris
- Sumitomo Dainippon
- Merck
- Beximco
- Inhalable & Nasal Spray
- Oral
- Others
- Hospital
- Drugs Store
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global COPD Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global COPD Medicine Market Perspective (2018-2029)
2.2 COPD Medicine Growth Trends by Region
2.2.1 Global COPD Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 COPD Medicine Historic Market Size by Region (2018-2023)
2.2.3 COPD Medicine Forecasted Market Size by Region (2024-2029)
2.3 COPD Medicine Market Dynamics
2.3.1 COPD Medicine Industry Trends
2.3.2 COPD Medicine Market Drivers
2.3.3 COPD Medicine Market Challenges
2.3.4 COPD Medicine Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top COPD Medicine Players by Revenue
3.1.1 Global Top COPD Medicine Players by Revenue (2018-2023)
3.1.2 Global COPD Medicine Revenue Market Share by Players (2018-2023)
3.2 Global COPD Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COPD Medicine Revenue
3.4 Global COPD Medicine Market Concentration Ratio
3.4.1 Global COPD Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Medicine Revenue in 2022
3.5 COPD Medicine Key Players Head office and Area Served
3.6 Key Players COPD Medicine Product Solution and Service
3.7 Date of Enter into COPD Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD MEDICINE BREAKDOWN DATA BY TYPE
4.1 Global COPD Medicine Historic Market Size by Type (2018-2023)
4.2 Global COPD Medicine Forecasted Market Size by Type (2024-2029)
5 COPD MEDICINE BREAKDOWN DATA BY APPLICATION
5.1 Global COPD Medicine Historic Market Size by Application (2018-2023)
5.2 Global COPD Medicine Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America COPD Medicine Market Size (2018-2029)
6.2 North America COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America COPD Medicine Market Size by Country (2018-2023)
6.4 North America COPD Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe COPD Medicine Market Size (2018-2029)
7.2 Europe COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe COPD Medicine Market Size by Country (2018-2023)
7.4 Europe COPD Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific COPD Medicine Market Size (2018-2029)
8.2 Asia-Pacific COPD Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific COPD Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific COPD Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America COPD Medicine Market Size (2018-2029)
9.2 Latin America COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America COPD Medicine Market Size by Country (2018-2023)
9.4 Latin America COPD Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa COPD Medicine Market Size (2018-2029)
10.2 Middle East & Africa COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa COPD Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa COPD Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK COPD Medicine Introduction
11.1.4 GSK Revenue in COPD Medicine Business (2018-2023)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Medicine Introduction
11.2.4 AstraZeneca Revenue in COPD Medicine Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim COPD Medicine Introduction
11.3.4 Boehringer Ingelheim Revenue in COPD Medicine Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Detail
11.4.2 Vertex Business Overview
11.4.3 Vertex COPD Medicine Introduction
11.4.4 Vertex Revenue in COPD Medicine Business (2018-2023)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche COPD Medicine Introduction
11.5.4 Roche Revenue in COPD Medicine Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis COPD Medicine Introduction
11.6.4 Novartis Revenue in COPD Medicine Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva COPD Medicine Introduction
11.7.4 Teva Revenue in COPD Medicine Business (2018-2023)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Detail
11.8.2 Chiesi Business Overview
11.8.3 Chiesi COPD Medicine Introduction
11.8.4 Chiesi Revenue in COPD Medicine Business (2018-2023)
11.8.5 Chiesi Recent Development
11.9 Viatris
11.9.1 Viatris Company Detail
11.9.2 Viatris Business Overview
11.9.3 Viatris COPD Medicine Introduction
11.9.4 Viatris Revenue in COPD Medicine Business (2018-2023)
11.9.5 Viatris Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Detail
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon COPD Medicine Introduction
11.10.4 Sumitomo Dainippon Revenue in COPD Medicine Business (2018-2023)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck COPD Medicine Introduction
11.11.4 Merck Revenue in COPD Medicine Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Beximco
11.12.1 Beximco Company Detail
11.12.2 Beximco Business Overview
11.12.3 Beximco COPD Medicine Introduction
11.12.4 Beximco Revenue in COPD Medicine Business (2018-2023)
11.12.5 Beximco Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global COPD Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global COPD Medicine Market Perspective (2018-2029)
2.2 COPD Medicine Growth Trends by Region
2.2.1 Global COPD Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 COPD Medicine Historic Market Size by Region (2018-2023)
2.2.3 COPD Medicine Forecasted Market Size by Region (2024-2029)
2.3 COPD Medicine Market Dynamics
2.3.1 COPD Medicine Industry Trends
2.3.2 COPD Medicine Market Drivers
2.3.3 COPD Medicine Market Challenges
2.3.4 COPD Medicine Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top COPD Medicine Players by Revenue
3.1.1 Global Top COPD Medicine Players by Revenue (2018-2023)
3.1.2 Global COPD Medicine Revenue Market Share by Players (2018-2023)
3.2 Global COPD Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COPD Medicine Revenue
3.4 Global COPD Medicine Market Concentration Ratio
3.4.1 Global COPD Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Medicine Revenue in 2022
3.5 COPD Medicine Key Players Head office and Area Served
3.6 Key Players COPD Medicine Product Solution and Service
3.7 Date of Enter into COPD Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD MEDICINE BREAKDOWN DATA BY TYPE
4.1 Global COPD Medicine Historic Market Size by Type (2018-2023)
4.2 Global COPD Medicine Forecasted Market Size by Type (2024-2029)
5 COPD MEDICINE BREAKDOWN DATA BY APPLICATION
5.1 Global COPD Medicine Historic Market Size by Application (2018-2023)
5.2 Global COPD Medicine Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America COPD Medicine Market Size (2018-2029)
6.2 North America COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America COPD Medicine Market Size by Country (2018-2023)
6.4 North America COPD Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe COPD Medicine Market Size (2018-2029)
7.2 Europe COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe COPD Medicine Market Size by Country (2018-2023)
7.4 Europe COPD Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific COPD Medicine Market Size (2018-2029)
8.2 Asia-Pacific COPD Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific COPD Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific COPD Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America COPD Medicine Market Size (2018-2029)
9.2 Latin America COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America COPD Medicine Market Size by Country (2018-2023)
9.4 Latin America COPD Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa COPD Medicine Market Size (2018-2029)
10.2 Middle East & Africa COPD Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa COPD Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa COPD Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK COPD Medicine Introduction
11.1.4 GSK Revenue in COPD Medicine Business (2018-2023)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Medicine Introduction
11.2.4 AstraZeneca Revenue in COPD Medicine Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim COPD Medicine Introduction
11.3.4 Boehringer Ingelheim Revenue in COPD Medicine Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Detail
11.4.2 Vertex Business Overview
11.4.3 Vertex COPD Medicine Introduction
11.4.4 Vertex Revenue in COPD Medicine Business (2018-2023)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche COPD Medicine Introduction
11.5.4 Roche Revenue in COPD Medicine Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis COPD Medicine Introduction
11.6.4 Novartis Revenue in COPD Medicine Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva COPD Medicine Introduction
11.7.4 Teva Revenue in COPD Medicine Business (2018-2023)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Detail
11.8.2 Chiesi Business Overview
11.8.3 Chiesi COPD Medicine Introduction
11.8.4 Chiesi Revenue in COPD Medicine Business (2018-2023)
11.8.5 Chiesi Recent Development
11.9 Viatris
11.9.1 Viatris Company Detail
11.9.2 Viatris Business Overview
11.9.3 Viatris COPD Medicine Introduction
11.9.4 Viatris Revenue in COPD Medicine Business (2018-2023)
11.9.5 Viatris Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Detail
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon COPD Medicine Introduction
11.10.4 Sumitomo Dainippon Revenue in COPD Medicine Business (2018-2023)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck COPD Medicine Introduction
11.11.4 Merck Revenue in COPD Medicine Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Beximco
11.12.1 Beximco Company Detail
11.12.2 Beximco Business Overview
11.12.3 Beximco COPD Medicine Introduction
11.12.4 Beximco Revenue in COPD Medicine Business (2018-2023)
11.12.5 Beximco Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global COPD Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Inhalable & Nasal Spray
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global COPD Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global COPD Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global COPD Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global COPD Medicine Market Share by Region (2018-2023)
Table 9. Global COPD Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global COPD Medicine Market Share by Region (2024-2029)
Table 11. COPD Medicine Market Trends
Table 12. COPD Medicine Market Drivers
Table 13. COPD Medicine Market Challenges
Table 14. COPD Medicine Market Restraints
Table 15. Global COPD Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global COPD Medicine Market Share by Players (2018-2023)
Table 17. Global Top COPD Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Medicine as of 2022)
Table 18. Ranking of Global Top COPD Medicine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by COPD Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COPD Medicine Product Solution and Service
Table 22. Date of Enter into COPD Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global COPD Medicine Revenue Market Share by Type (2018-2023)
Table 26. Global COPD Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global COPD Medicine Revenue Market Share by Type (2024-2029)
Table 28. Global COPD Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global COPD Medicine Revenue Market Share by Application (2018-2023)
Table 30. Global COPD Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global COPD Medicine Revenue Market Share by Application (2024-2029)
Table 32. North America COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific COPD Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific COPD Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific COPD Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 47. GSK Company Detail
Table 48. GSK Business Overview
Table 49. GSK COPD Medicine Product
Table 50. GSK Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 51. GSK Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca COPD Medicine Product
Table 55. AstraZeneca Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim COPD Medicine Product
Table 60. Boehringer Ingelheim Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Vertex Company Detail
Table 63. Vertex Business Overview
Table 64. Vertex COPD Medicine Product
Table 65. Vertex Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 66. Vertex Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche COPD Medicine Product
Table 70. Roche Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis COPD Medicine Product
Table 75. Novartis Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Company Detail
Table 78. Teva Business Overview
Table 79. Teva COPD Medicine Product
Table 80. Teva Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Chiesi Company Detail
Table 83. Chiesi Business Overview
Table 84. Chiesi COPD Medicine Product
Table 85. Chiesi Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 86. Chiesi Recent Development
Table 87. Viatris Company Detail
Table 88. Viatris Business Overview
Table 89. Viatris COPD Medicine Product
Table 90. Viatris Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 91. Viatris Recent Development
Table 92. Sumitomo Dainippon Company Detail
Table 93. Sumitomo Dainippon Business Overview
Table 94. Sumitomo Dainippon COPD Medicine Product
Table 95. Sumitomo Dainippon Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 96. Sumitomo Dainippon Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck COPD Medicine Product
Table 100. Merck Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Beximco Company Detail
Table 103. Beximco Business Overview
Table 104. Beximco COPD Medicine Product
Table 105. Beximco Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 106. Beximco Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 1. Global COPD Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Inhalable & Nasal Spray
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global COPD Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global COPD Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global COPD Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global COPD Medicine Market Share by Region (2018-2023)
Table 9. Global COPD Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global COPD Medicine Market Share by Region (2024-2029)
Table 11. COPD Medicine Market Trends
Table 12. COPD Medicine Market Drivers
Table 13. COPD Medicine Market Challenges
Table 14. COPD Medicine Market Restraints
Table 15. Global COPD Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global COPD Medicine Market Share by Players (2018-2023)
Table 17. Global Top COPD Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Medicine as of 2022)
Table 18. Ranking of Global Top COPD Medicine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by COPD Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COPD Medicine Product Solution and Service
Table 22. Date of Enter into COPD Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global COPD Medicine Revenue Market Share by Type (2018-2023)
Table 26. Global COPD Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global COPD Medicine Revenue Market Share by Type (2024-2029)
Table 28. Global COPD Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global COPD Medicine Revenue Market Share by Application (2018-2023)
Table 30. Global COPD Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global COPD Medicine Revenue Market Share by Application (2024-2029)
Table 32. North America COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific COPD Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific COPD Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific COPD Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa COPD Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa COPD Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa COPD Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 47. GSK Company Detail
Table 48. GSK Business Overview
Table 49. GSK COPD Medicine Product
Table 50. GSK Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 51. GSK Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca COPD Medicine Product
Table 55. AstraZeneca Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim COPD Medicine Product
Table 60. Boehringer Ingelheim Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Vertex Company Detail
Table 63. Vertex Business Overview
Table 64. Vertex COPD Medicine Product
Table 65. Vertex Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 66. Vertex Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche COPD Medicine Product
Table 70. Roche Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis COPD Medicine Product
Table 75. Novartis Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Company Detail
Table 78. Teva Business Overview
Table 79. Teva COPD Medicine Product
Table 80. Teva Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Chiesi Company Detail
Table 83. Chiesi Business Overview
Table 84. Chiesi COPD Medicine Product
Table 85. Chiesi Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 86. Chiesi Recent Development
Table 87. Viatris Company Detail
Table 88. Viatris Business Overview
Table 89. Viatris COPD Medicine Product
Table 90. Viatris Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 91. Viatris Recent Development
Table 92. Sumitomo Dainippon Company Detail
Table 93. Sumitomo Dainippon Business Overview
Table 94. Sumitomo Dainippon COPD Medicine Product
Table 95. Sumitomo Dainippon Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 96. Sumitomo Dainippon Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck COPD Medicine Product
Table 100. Merck Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Beximco Company Detail
Table 103. Beximco Business Overview
Table 104. Beximco COPD Medicine Product
Table 105. Beximco Revenue in COPD Medicine Business (2018-2023) & (US$ Million)
Table 106. Beximco Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global COPD Medicine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global COPD Medicine Market Share by Type: 2022 VS 2029
Figure 3. Inhalable & Nasal Spray Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global COPD Medicine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global COPD Medicine Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Drugs Store Case Studies
Figure 10. COPD Medicine Report Years Considered
Figure 11. Global COPD Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global COPD Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global COPD Medicine Market Share by Region: 2022 VS 2029
Figure 14. Global COPD Medicine Market Share by Players in 2022
Figure 15. Global Top COPD Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Medicine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by COPD Medicine Revenue in 2022
Figure 17. North America COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America COPD Medicine Market Share by Country (2018-2029)
Figure 19. United States COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe COPD Medicine Market Share by Country (2018-2029)
Figure 23. Germany COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific COPD Medicine Market Share by Region (2018-2029)
Figure 31. China COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America COPD Medicine Market Share by Country (2018-2029)
Figure 39. Mexico COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa COPD Medicine Market Share by Country (2018-2029)
Figure 43. Turkey COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 46. AstraZeneca Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 48. Vertex Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 52. Chiesi Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 53. Viatris Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 54. Sumitomo Dainippon Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 56. Beximco Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global COPD Medicine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global COPD Medicine Market Share by Type: 2022 VS 2029
Figure 3. Inhalable & Nasal Spray Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global COPD Medicine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global COPD Medicine Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Drugs Store Case Studies
Figure 10. COPD Medicine Report Years Considered
Figure 11. Global COPD Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global COPD Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global COPD Medicine Market Share by Region: 2022 VS 2029
Figure 14. Global COPD Medicine Market Share by Players in 2022
Figure 15. Global Top COPD Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Medicine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by COPD Medicine Revenue in 2022
Figure 17. North America COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America COPD Medicine Market Share by Country (2018-2029)
Figure 19. United States COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe COPD Medicine Market Share by Country (2018-2029)
Figure 23. Germany COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific COPD Medicine Market Share by Region (2018-2029)
Figure 31. China COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America COPD Medicine Market Share by Country (2018-2029)
Figure 39. Mexico COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa COPD Medicine Market Share by Country (2018-2029)
Figure 43. Turkey COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia COPD Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 46. AstraZeneca Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 48. Vertex Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 52. Chiesi Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 53. Viatris Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 54. Sumitomo Dainippon Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 56. Beximco Revenue Growth Rate in COPD Medicine Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
